ORION PHARMA A/S: Financial statements 2024
CVR: 20601116
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
ORION PHARMA A/S (CVR 20601116) has filed annual accounts for 2024. In 2024, the company reported revenue of DKK 309,011,374 and a net result of DKK 10,899,639 compared with DKK 8,232,002 the year before. That is an increase of 22.1% compared with the year before. The profit margin was 3.5%. Equity in the 2024 report amounted to DKK 31,984,677. The solvency ratio was 45.4%. The company had 15 employees in the financial year.
- Revenue
- DKK 309,011,374
- Gross Profit
- DKK 26,634,848
- Profit/Loss
- DKK 10,899,639
- Equity
- DKK 31,984,677
- Total Assets
- DKK 70,410,168
- Employees
- 15
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | 309M | 26.6M | 10.9M | 32M | 15 |
| 2023 | 253.1M | 25.1M | 8.2M | 51.7M | 16 |
| 2022 | 214.2M | 24.9M | 7.5M | 50.5M | 16 |
| 2021 | 212.5M | 20.7M | 4.5M | 47.9M | 17 |
| 2020 | 282.9M | 25.5M | 6.3M | 51.4M | 20 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
ORION PHARMA A/S has won the tender "Amgros 2025 2.212.a" issued by Amgros I/S worth 14,666,754 DKK.
ORION PHARMA A/S has won the tender "Amgros 2025 1.1391.b" issued by Amgros I/S worth 74,708,177 DKK.
ORION PHARMA A/S has won the tender "Amgros 2025 1.700.a" issued by Amgros I/S worth 313,301,544 DKK.
ORION PHARMA A/S has won the tender "Amgros 2025 1.1305.a" issued by Amgros I/S worth 91,145,340 DKK.
ORION PHARMA A/S has won the tender "Joint Nordic Procurement of Pharmaceuticals - 2025 - NF2.1301.a" issued by Amgros I/S worth 227,000,000 EUR.
ORION PHARMA A/S has published its annual report for 2023. Revenue came to DKK 253,050,082, and the net result was DKK 8,232,002.
As of April 22, 2024, René Kristian Lindell has joined the board of directors of ORION PHARMA A/S.
As of April 22, 2024, Jari Ilmari Karlson has left the board of directors of ORION PHARMA A/S.
About ORION PHARMA A/S
ORION PHARMA A/S is a Danish company of the type Aktieselskab based in København S, founded in 1953. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named ERCOPHARM A/S. The management consists of Jesper Otto Qvist-Pedersen. The board consists of Satu Maarit Ahomäki (chair), Mikko Tapani Kemppainen and René Kristian Lindell. The company is owned by Orion Corporation. The company has 14 employees (2026). In 2025, the company reported revenue of DKK 329,561,856 and a net result of DKK 10,525,947 compared with DKK 10,899,639 the year before. Equity in the 2025 report amounted to DKK 32,510,625.